...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Pfizer seems like a good fit for a BP deal

"Nothing is perfect. But it may not be all that bad if we're governed by HL! "

Yep, hard to believe it could possibly be any worse!

 

Share
New Message
Please login to post a reply